Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD

Research output: Contribution to journalLetterpeer-review

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)1945-1946.e1
JournalOphthalmology
Volume120
Issue number9
DOIs
StatePublished - Sep 2013

ASJC Scopus subject areas

  • Ophthalmology

Cite this